Newsletter archive
Newsletter March 2021
Tumor Model Insights 03/2021:
Partially temozolomide resistant, IDH-wildtype glioblastoma PDX model (Glio10618)
Tumor Model Insights 03/2021:
Partially temozolomide resistant, IDH-wildtype glioblastoma PDX model (Glio10618)